Can a North Carolina resident get peptides by telehealth?
North Carolina regulates telemedicine prescribing mainly through North Carolina Medical Board Position Statement 5.1.4 (Telemedicine) rather than a practice statute. The Board's position is that an evaluation need not be in person if the licensee uses technology sufficient to accurately diagnose and treat the patient in conformity with the standard of care, that licensees prescribing by telemedicine must follow state and federal law, and that some circumstances, such as treating chronic pain with controlled substances, are not suitable for telemedicine-only care. The prescriber must hold a North Carolina license. The position statement does not approve questionnaire-only prescribing, so this record leaves asynchronous prescribing unconfirmed. None of the peptides in this database are controlled substances. [2]
How does the North Carolina pharmacy board treat compounding?
| Board | North Carolina Board of Pharmacy |
|---|---|
| Eligible substances | Follows the federal 503A framework |
The Board of Pharmacy issues pharmacy permits under the North Carolina Pharmacy Practice Act (G.S. Chapter 90, Article 4A) and adopts rules in 21 NCAC 46, including the compounding rule in Section .2800. Under G.S. 90-85.21A, any pharmacy outside North Carolina that ships, mails, or delivers dispensed legend drugs into the state must register with the Board every year, and the Board may deny registration to a pharmacy disciplined in its home state for compounding or dispensing violations that threaten public health. The Board's July 2023 newsletter (Vol. 45, No. 1, Item 2465, "Statement Concerning Semaglutide Compounding") announced a Board staff guidance document on when federal law permits compounding a copy of a commercially available drug and how that applies to semaglutide; the Board's general pharmacy FAQ says the statement was updated after FDA's April 2023 clarification of semaglutide's shortage status, but the linked statement itself could not be retrieved from the Board's site when this record was checked, so its specific terms are not summarized here. The same FAQ now says FDA found semaglutide injection shortages resolved and would not act against state-licensed 503A pharmacies only until April 22, 2025, and that compounding copies of approved tirzepatide products is no longer allowed. North Carolina has no state bulks list; peptide eligibility follows the federal 503A framework. [1] [3] [4] [5] [6] [8]
Can you get compounded GLP-1s in North Carolina?
Any out-of-state pharmacy shipping compounded GLP-1s in must hold an annual G.S. 90-85.21A registration. [3] [5] [11]
Prices by channel: semaglutide cost, tirzepatide cost.
Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.
What is the legal access path in North Carolina?
Verified access options
Prescriber licensed in North Carolina, in person or by telehealth
Telehealth prescribing of non-controlled peptides is permitted in North Carolina. Whether questionnaire-only prescribing is permitted is not clearly settled, so expect a live visit.
Pharmacy licensed or registered with the North Carolina Board of Pharmacy
Check the dispensing pharmacy against the board's license lookup before paying, including out-of-state mail-order pharmacies.
Branded GLP-1 through a retail or manufacturer pharmacy
FDA approved semaglutide and tirzepatide are available by prescription. Compounded GLP-1 limited; see the GLP-1 section for why.
Access paths are verified against public regulatory records and prescriber licensing. We never list unlicensed vendors.
Find a provider in North Carolina
Is it legal to buy research peptides in North Carolina?
The North Carolina Food, Drug, and Cosmetic Act (G.S. 106-120 and following) prohibits selling adulterated or misbranded drugs, and the Pharmacy Practice Act restricts dispensing of legend drugs to permitted pharmacies. [4] [7] [12]
Peptide-specific notes for North Carolina
| Peptide | Note |
|---|---|
| Semaglutide | Available branded by prescription, including by telemedicine from a North Carolina-licensed prescriber. Compounded semaglutide is limited to the federal patient specific exception since April 22, 2025, the date the North Carolina Board of Pharmacy's FAQ gives for the end of FDA's grace period for 503A pharmacies. [6] [11] |
Frequently asked questions
Can I get a GLP-1 prescription in North Carolina through telemedicine?
Yes, from a North Carolina-licensed prescriber. The North Carolina Medical Board's telemedicine position says an evaluation need not be in person if the technology is sufficient to diagnose and treat under the standard of care, and semaglutide and tirzepatide are not controlled substances. [2]
Does North Carolina have a telehealth statute?
Not a general practice statute. North Carolina relies on the Medical Board's telemedicine position statement and general licensing law, so the standard of care governs what evaluation is needed before prescribing. [2]
Can an out-of-state pharmacy ship compounded peptides to me in North Carolina?
Only if it registers annually with the North Carolina Board of Pharmacy under G.S. 90-85.21A. The Board can refuse registration to pharmacies disciplined at home for compounding violations. [1] [3]
What has the North Carolina Board of Pharmacy said about compounded semaglutide?
In 2023 Board staff issued a guidance statement on if, when, and how semaglutide may be compounded, announced in the Board's July 2023 newsletter. The Board's current FAQ says FDA found semaglutide injection shortages resolved and stopped extending enforcement discretion to 503A pharmacies after April 22, 2025, and that compounding copies of approved tirzepatide products is no longer allowed. [5] [6]
Can a North Carolina pharmacy compound BPC-157?
No, not from bulk today. BPC-157 is not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk. State boards cannot authorize what federal law does not. Peptides still in FDA Category 2 cannot be compounded either. [8] [9] [10]
Sources
Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, and federal FDA guidance.
- [1]North Carolina Board of Pharmacy
- [2]North Carolina Medical Board Position Statement 5.1.4, Telemedicine
- [3]N.C. G.S. 90-85.21A, Pharmacies outside North Carolina (nonresident registration)
- [4]N.C. G.S. Chapter 90, Article 4A, North Carolina Pharmacy Practice Act
- [6]North Carolina Board of Pharmacy: General pharmacy FAQs (compounding GLP-1s and semaglutide)
- [7]N.C. G.S. Chapter 106, Article 12, Food, Drug, and Cosmetic Act
- [8]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
- [9]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
- [10]FDA: Pharmacy Compounding Advisory CommitteeFDA
- [11]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
- [12]21 U.S.C. 331, Prohibited acts
Cite this page
Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.
- APA style
PeptideAgent. (2026, September 22). Are peptides legal in North Carolina?. https://peptideagent.ai/legal/north-carolina- HTML link
<a href="https://peptideagent.ai/legal/north-carolina">Are peptides legal in North Carolina?</a>, PeptideAgent, updated September 22, 2026.